2023 State of Specialty Spend & Trend Report
Plus
SOLUTIONS
Artemetrx Plus
Maximize your ability to improve financial and clinical outcomes with the industry’s best drug cost management experts. Artemetrx Plus wraps your team with hands on support from our pharmacists and analysts to maximize your ability to transform data into actionable insights. With the extensive knowledge and best practices of our team, you will be advised on opportunities to capture more savings opportunities with optimal clinical outcomes.
Artemetrx savings identified in 2023
pharmacy & medical claims
integrated lives on Artemetrx
Artemetrx Plus Provides
Best Practice Insights and Training
Our team of clinicians and analysts will serve as an extension of your team to identify data-driven opportunities to improve financial and clinical outcomes. They augment recommendations with insights as to how plans are approaching drug cost management. Additionally, the Artemetrx Client Success team offers continuous training and best practice recommendations to help your team optimize the use of the platform and tools.
Clinical Consulting
Artemetrx clinical consultants are the trusted advisors to many health plans and employers who rely on their expertise to identify and present actionable recommendations based on integrated data. This team is well-versed in utilizing data to identify and track opportunities. They become an extension of your team that understands your strategy and supports you along the process. Once the client accepts recommendations, we help to track results so that you can report the results achieved to leaders and clients.
Integrated Diagnostic
This extensive analysis is based on our proprietary opportunity toolset that examines your unique data and identifies a series of opportunities for improved clinical or financial outcomes. Focus areas include formulary management, reimbursement management, clinical optimization, and fraud waste and abuse (FWA). Analytics with recommendations are presented to you, and then we help develop a strategic roadmap for the next 1-3 years.